Ranbaxy: Latest News and Updates, Top Stories, Videos, Photos About Ranbaxy

Sun Pharma Crashes 6% To A New 52-Week Low

Shares in Sun Pharma slumped a huge 6 per cent after profits at the company crashed by 46 per cent to Rs 1107 crores for the quarter ending Sept 30, 2015. The stock hit a 52-week low of Rs 744 ...

Sun Pharma Shares Up On Patent Litigation Settlement

Shares of the Sun Pharmaceutical Industries was seen trading higher on Tuesday after the company announced that Ranbaxy Pharmaceuticals, a wholly-owned subsidiary entered into a Settlement Agreement with Actavis that dismisses the patent litigation suit relating to Actavis. Check the share ...

Sun Pharma Rallies On BofA-ML Upgrade

Shares in Sun Pharma gained more than 2 percent to Rs 909, after BofA-ML upgraded the stock to "buy" from "neutral", raising its target price to Rs 1,070. Shares in Sun Pharma have seen some buying support in the last ...

Sun Pharma Shares Fall 14% On Profit, Revenue Warning

Shares in Sun Pharma fell a huge 14 per cent after the company warned of revenues remaining flat and profits being impacted in 2015-16. The stock was last trading at Rs 820, down 14 per cent over Monday's close. Check ...

Sun Pharma-Ranbaxy USD 4 Billion Merger Completed

Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries on Tuesday said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals. In a filing to the Bombay Stock Exchange (BSE), the company said ...

Sun Pharma, Ranbaxy Stocks Rally on Merger Approval

Shares of Sun Pharma and Ranbaxy surged in trade in Monday after the companies received a nod from the U.S. Federal Trade Commission. The company today announced that the U.S. Federal Trade Commission (FTC) has completed its review of the ...

Ranbaxy Rallies as CCI Approves Deal with Sun Pharma

Shares in Ranbaxy rallied more than three per cent after CCI approved a deal with Sun Pharma. The stock was up almost 3 per cent at Rs 643. It maybe recalled that earlier this year Sun Pharma said that they ...

Ranbaxy sues US FDA; Stock Slips

Ranbaxy has filed a complaint against the U.S. FDA in federal court and has also asked the Court for a temporary restraining order to prevent any further action by FDA until Ranbaxy's case is decided, the company said in the press ...

Sun Pharma-Ranbaxy deal gets BSE, NSE clearance

New Delhi: The USD 4-billion merger of Ranbaxy Labs with Sun Pharmaceutical has got clearance from the two leading stock exchanges -- BSE and NSE. The 'no-objection' from the two exchanges would allow the two companies to file their scheme ...

M&A values in India up 31% at $23 bn

Value of mergers and acquisitions in India during the first half of this year increased by 30.68 percent to USD 23 billion year-on-year, a Grant Thornton report said on Friday. In the first six months of 2014, mergers and acquisitions ...

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US market with 180-days of marketing exclusivity. Ohm Laboratories Inc, a ...

Sensex zooms past 25,000 points ahead of Modi’s swearing-in ceremony

The Sensex and the Nifty surged in trade ahead of Modi's swearing-in ceremony as the Prime Minister of the country continuing the buoyancy witnessed in the last few trading sessions on economic hopes set to be ushered in by the new ...

Ranbaxy News